QA09.7

ICD-11 MMS 2026-01

Special screening examination for neoplasm of skin

Description

Attendance for special screening for skin cancer including whole skin surface photographic or dermoscopic documentation of patients with multiple melanocytic naevi or naevoid basal cell carcinoma syndrome.

Index terms

  • Special screening examination for neoplasm of skin
  • Skin cancer surveillance
  • Mole mapping

Exclusions from above levels

  • http://id.who.int/icd/entity/1144140024 – examinations related to pregnancy and reproduction
  • http://id.who.int/icd/entity/1617090159 – Clinical findings in blood, blood-forming organs, or the immune system

Sibling codes

  • QA09.0 – Special screening examination for neoplasm of stomach
  • QA09.1 – Special screening examination for neoplasm of intestinal tract
  • QA09.2 – Special screening examination for neoplasm of respiratory organs
  • QA09.3 – Special screening examination for neoplasm of breast
  • QA09.4 – Special screening examination for neoplasm of cervix
  • QA09.5 – Special screening examination for neoplasm of prostate
  • QA09.6 – Special screening examination for neoplasm of bladder
  • QA09.Y – Other specified special screening examination for neoplasms
  • QA09.Z – Special screening for neoplasm of unspecified site

Foundation entity

Special screening examination for neoplasm of skin – http://id.who.int/icd/entity/1374181072

Allowed postcoordination axes

Part of: QA09: Special screening examination for neoplasms › 24: Factors influencing health status or contact with health services